Question · asked by 1 review
Methotrexate vs alternative disease‐modifying antirheumatic drugs: Function
- Population
- children and young people with JIA
- Intervention
- Methotrexate
- Comparison
- alternative disease‐modifying antirheumatic drugs
- Outcome
- Function
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Methotrexate vs alternative disease‐modifying antirheumatic drugs Function · children and young people with JIA Methotrexate for juvenile idiopathic arthritis (2024) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 94 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Methotrexate for juvenile idiopathic arthritis 2024 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
Related questions
The same intervention and outcome, asked in another population or against another comparator.
- Methotrexate vs placebo · psoriatic arthritis · 1 review
- Methotrexate vs placebo · children and young people with JIA · 1 review
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.